JP2024529343A5 - - Google Patents
Info
- Publication number
- JP2024529343A5 JP2024529343A5 JP2024501751A JP2024501751A JP2024529343A5 JP 2024529343 A5 JP2024529343 A5 JP 2024529343A5 JP 2024501751 A JP2024501751 A JP 2024501751A JP 2024501751 A JP2024501751 A JP 2024501751A JP 2024529343 A5 JP2024529343 A5 JP 2024529343A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- peg
- itr
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163221290P | 2021-07-13 | 2021-07-13 | |
| US63/221,290 | 2021-07-13 | ||
| PCT/US2022/036930 WO2023287861A2 (en) | 2021-07-13 | 2022-07-13 | Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529343A JP2024529343A (ja) | 2024-08-06 |
| JP2024529343A5 true JP2024529343A5 (enExample) | 2025-07-16 |
Family
ID=84920581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501751A Pending JP2024529343A (ja) | 2021-07-13 | 2022-07-13 | 一本鎖可変断片（ｓｃＦｖ）修飾脂質ナノ粒子組成物及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240382432A1 (enExample) |
| EP (1) | EP4370135A4 (enExample) |
| JP (1) | JP2024529343A (enExample) |
| KR (1) | KR20240035821A (enExample) |
| CN (1) | CN118159278A (enExample) |
| AU (1) | AU2022311904A1 (enExample) |
| CA (1) | CA3225694A1 (enExample) |
| IL (1) | IL309767A (enExample) |
| MX (1) | MX2024000670A (enExample) |
| WO (1) | WO2023287861A2 (enExample) |
| ZA (1) | ZA202400158B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL309767A (en) * | 2021-07-13 | 2024-02-01 | Generation Bio Co | Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereof |
| US20240226133A1 (en) * | 2023-01-09 | 2024-07-11 | Claudia Chimisso Dos Santos | Microrna-based particle for the treatment of dysregulated immune response |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025090417A1 (en) | 2023-10-24 | 2025-05-01 | Generation Bio Co. | Bispecific stealth lipid nanoparticle compositions for cell targeting |
| WO2025090138A1 (en) * | 2023-10-24 | 2025-05-01 | Generation Bio Co. | Stealth lipid nanoparticle compositions for cell targeting |
| WO2025150516A1 (ja) * | 2024-01-12 | 2025-07-17 | 日油株式会社 | 核酸内封脂質ナノ粒子を含む凍結組成物 |
| WO2026085495A1 (en) | 2024-10-18 | 2026-04-23 | Generation Bio Co. | Synthetic partially single-stranded nucleic acid compositions and uses and methods therefor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11254744B2 (en) * | 2015-08-07 | 2022-02-22 | Imaginab, Inc. | Antigen binding constructs to target molecules |
| US11617797B2 (en) * | 2017-04-28 | 2023-04-04 | David T. Tran | Multi-targeted multi-valent ligand drug particles for the treatment and prevention of diseases and conditions |
| US20200093936A1 (en) * | 2018-09-21 | 2020-03-26 | The Trustees Of The University Of Pennsylvania | Therapeutic Targeting of Lipid Nanoparticles |
| CN121422256A (zh) * | 2019-12-04 | 2026-01-30 | 奥纳治疗公司 | 环状rna组合物和方法 |
| IL309767A (en) * | 2021-07-13 | 2024-02-01 | Generation Bio Co | Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereof |
-
2022
- 2022-07-13 IL IL309767A patent/IL309767A/en unknown
- 2022-07-13 AU AU2022311904A patent/AU2022311904A1/en active Pending
- 2022-07-13 MX MX2024000670A patent/MX2024000670A/es unknown
- 2022-07-13 WO PCT/US2022/036930 patent/WO2023287861A2/en not_active Ceased
- 2022-07-13 US US18/578,073 patent/US20240382432A1/en active Pending
- 2022-07-13 CN CN202280055244.2A patent/CN118159278A/zh active Pending
- 2022-07-13 JP JP2024501751A patent/JP2024529343A/ja active Pending
- 2022-07-13 KR KR1020247004144A patent/KR20240035821A/ko active Pending
- 2022-07-13 EP EP22842796.9A patent/EP4370135A4/en active Pending
- 2022-07-13 CA CA3225694A patent/CA3225694A1/en active Pending
-
2024
- 2024-01-03 ZA ZA2024/00158A patent/ZA202400158B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024529343A5 (enExample) | ||
| Kulkarni et al. | The current landscape of nucleic acid therapeutics | |
| Cheng et al. | The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery | |
| JP2023534043A5 (enExample) | ||
| JP4764426B2 (ja) | カチオン性脂質および使用方法 | |
| JP2024520756A5 (enExample) | ||
| KR20230052895A (ko) | 폴리뉴클레오타이드를 감소된 크기의 지질 나노입자로 캡슐화하는 방법 및 신규한 지질 나노입자 제형 | |
| US20060051405A1 (en) | Compositions for the delivery of therapeutic agents and uses thereof | |
| JP2022546597A5 (enExample) | ||
| JP2024520756A (ja) | ＡｐｏＥ及びＡｐｏＢ修飾脂質ナノ粒子組成物及びその使用 | |
| JP2022546597A (ja) | 閉端ｄｎａおよび切断可能脂質を含む脂質ナノ粒子組成物ならびにそれらの使用方法 | |
| JP2023518985A (ja) | 新規脂質及びそれらのナノ粒子組成物 | |
| CN101163796B (zh) | 阳离子脂质及应用方法 | |
| US20240382432A1 (en) | Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereof | |
| CA2569664A1 (en) | Lipid encapsulated interfering rna | |
| JP2011529912A (ja) | 核酸送達システム用のナノ粒子組成物 | |
| JP2024517644A5 (enExample) | ||
| JP2024522692A5 (enExample) | ||
| CA3222589A1 (en) | Cationic lipids and compositions thereof | |
| JP2023527747A (ja) | 新規脂質及びそれらのナノ粒子組成物 | |
| JP2025541727A (ja) | 新規のポリグリセロールコンジュゲート脂質及びそれを含む脂質ナノ粒子組成物 | |
| EP4626402A1 (en) | Lipid nanoparticles comprising nucleic acids and lipid-anchored polymers | |
| AU2023283348A1 (en) | Lipid nanoparticle compositions and uses thereof | |
| JP2025540076A (ja) | 核酸、イオン化可能な脂質、ステロール、脂質アンカーポリマー、及びヘルパー脂質を含む脂質ナノ粒子、それらの使用 | |
| RU2023136316A (ru) | КОМПОЗИЦИИ МОДИФИЦИРОВАННЫХ ЛИПИДНЫХ НАНОЧАСТИЦ С ОДНОЦЕПОЧЕЧНЫМ ВАРИАБЕЛЬНЫМ ФРАГМЕНТОМ (scFv) И ИХ ПРИМЕНЕНИЯ |